What the business is, and whether it's a good one at a fair price.
Manufactures and sells pharmaceutical active ingredients, with a focus on pain management APIs. Runs contract development and manufacturing projects for global innovator drug companies, with 3 molecules currently under development for 2 such companies, and has filed 21 Drug Master Files to date. In Q1 FY27, acquired a 63.98% stake in Remember India Health Links to enter finished dosage formulations, bringing in 30+ formulation dossiers, and incorporated two new subsidiaries to build a presence in peptides/biosimilars and surgical implants/medical devices. Sells to pharmaceutical, nutraceutical, veterinary and personal care customers across 15+ countries and has begun diversifying into industrial and fine chemicals. Raw materials form the bulk of operating costs, with depreciation and employee costs making up smaller shares.
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from ANLON HEALTHCARE LIMITED's filed financials and exchange disclosures
ANLON HEALTHCARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol AHCL.
Not in the latest reported year — ANLON HEALTHCARE LIMITED's dividend payout for FY26 was nil.
No. Debt stands at 0.17× equity, and it carries net debt of ₹39 Cr. That is lower than 46% of its 171 Pharmaceuticals peers.
On trailing P/E, ANLON HEALTHCARE LIMITED ranks 19 of 169 in Pharmaceuticals — cheaper than 89% of them, against an industry median of 28.9×. This is a position, not a valuation judgement.
On a typical session ANLON HEALTHCARE LIMITED moves 1.50% — that is the median absolute close-to-close move across its last 253 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by ANLON HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
